Hint mode is switched on Switch off
For swift navigation between sections

OKYO Pharma
LEI 213800VVN5CB56Y15A05

Organization name
OKYO Pharma Limited
Country name
Guernsey
Country of registration
Guernsey
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds
  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

OKYO Pharma Limited is a life sciences and biotechnology company. OKYO Pharma focuses on diseases of high unmet need, where large market potential exists for effective therapeutics.

Awards

Documentation

IFRS/US GAAP reports

2025
2023
2022
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Codes

  • LEI
    213800VVN5CB56Y15A05
  • SIC
    6799 INVESTORS, NEC
  • CIK
    0001849296
Registration is required to get access.